NCT02646085View on ClinicalTrials.gov

Multiparametric Imaging in Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Multiple Myeloma
Interventions
DRUG

C11 Methionine positron emission tomography

diagnostic positron emission tomography imaging after intravenous injection of C11 Methionine

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Yingbing Wang

OTHER

NCT02646085 - Multiparametric Imaging in Multiple Myeloma | Biotech Hunter | Biotech Hunter